- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 353687, 21 pages
The Biochemistry and Regulation of S100A10: A Multifunctional Plasminogen Receptor Involved in Oncogenesis
1Centro de Biomedicina Molecular e Estrutural, University of Algarve, Campus of Gambelas, FCT Bld. 8, 8005-139 Faro, Portugal
2Department of Biochemistry & Molecular Biology, Dalhousie University, P.O. Box 1500, Halifax, NS, Canada B3H 4R2
3Department of Pathology, Dalhousie University, P.O. Box 1500, Halifax, NS, Canada B3H 4R2
Received 9 April 2012; Accepted 1 June 2012
Academic Editor: Lindsey A. Miles
Copyright © 2012 Patricia A. Madureira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [18 citations]
The following is the list of published articles that have cited the current article.
- Paul A. O'Connell, and David M. Waisman, “Regulation of plasmin generation by the annexin A2 heterotetramer: A shift in perspective,” Future Oncology, vol. 8, no. 7, pp. 763–765, 2012.
- Jinfu Shang, Zhanxue Zhang, Weiqing Song, Baojun Zhou, Yuesheng Zhang, Guixin Li, and Shaofan Qiu, “S100A10 as a novel biomarker in colorectal cancer,” Tumor Biology, 2013.
- Aneta Kasza, “Signal-dependent Elk-1 target genes involved in transcript processing and cell migration,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013.
- Patrícia A. Madureira, and David M. Waisman, “Annexin A2: The importance of being redox sensitive,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 3568–3594, 2013.
- Juan F. Santibanez, “Transforming Growth Factor-Beta and Urokinase-Type Plasminogen Activator: Dangerous Partners in Tumorigenesis—Implications in Skin Cancer,” ISRN Dermatology, vol. 2013, pp. 1–26, 2013.
- Moamen Bydoun, Ryan Holloway, David Waisman, and Alamelu Bharadwaj, “Annexin A2 Heterotetramer: Structure and Function,” International Journal Of Molecular Sciences, vol. 14, no. 3, pp. 6259–6305, 2013.
- Michelle A. Ozbun, and Agnieszka Dziduszko, “Annexin A2 and S100A10 Regulate Human Papillomavirus Type 16 Entry and Intracellular Trafficking in Human Keratinocytes,” Journal Of Virology, vol. 87, no. 13, pp. 7502–7515, 2013.
- Lindseya. Miles, and Robertj. Parmer, “Plasminogen receptors: The first quarter century,” Seminars in Thrombosis and Hemostasis, vol. 39, no. 4, pp. 329–337, 2013.
- Ioannis Panagopoulos, Petter Brandal, Ludmila Gorunova, Bodil Bjerkehagen, and Sverre Heim, “Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors,” International Journal of Oncology, vol. 44, no. 5, pp. 1425–1432, 2014.
- Yidong Liu, Helene K Myrvang, and Lodewijk V Dekker, “Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation,” British Journal of Pharmacology, 2014.
- Jun-Song Liu, Shi-Cai He, Zheng-Liang Zhang, Rui Chen, Lin Fan, Guang-Lin Qiu, Shuai Chang, Liang Li, and Xiang-Ming Che, “Anticancer effects of beta-elemene in gastric cancer cells and its potential underlying proteins: A proteomic study,” Oncology Reports, vol. 32, no. 6, pp. 2635–2647, 2014.
- Moamen Bydoun, and David M Waisman, “On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity,” Future Oncology, vol. 10, no. 15, pp. 2469–2479, 2014.
- Varsha Meghnani, Anil Wagh, Venkata S.K. Indurthi, Mohit Koladia, Stefan W. Vetter, Benedict Law, and Estelle Leclerc, “The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors,” The International Journal of Biochemistry & Cell Biology, 2014.
- Jungha Park, Takayuki Yamaura, Jun Kawamoto, Tatsuo Kurihara, and Satoshi B. Sato, “Reciprocal Modulation of Surface Expression of Annexin A2 in a Human Umbilical Vein Endothelial Cell-Derived Cell Line by Eicosapentaenoic Acid and Docosahexaenoic Acid,” Plos One, vol. 9, no. 1, 2014.
- Juan Manuel Teijeiro, María Lorena Roldán, and Patricia Estela Marini, “Annexin A2 and S100A10 in the mammalian oviduct,” Cell and Tissue Research, 2015.
- Yuehua Han, Jun Ye, Ying Dong, Zhipeng Xu, and Qin Du, “Expression and significance of annexin A2 in patients with gastric adenocarcinoma and the association with E-cadherin,” Experimental And Therapeutic Medicine, vol. 10, no. 2, pp. 549–554, 2015.
- Shu-Le Jiang, Dong-Yan Pan, Chao Gu, Hai-Feng Qin, and Shi-Hong Zhao, “Annexin A2 silencing enhances apoptosis of human umbilical vein endothelial cells in vitro,” Asian Pacific Journal of Tropical Medicine, 2015.
- Noor A. Lokman, Carmen E. Pyragius, Andrew Ruszkiewicz, Martin K. Oehler, and Carmela Ricciardelli, “Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome,” Translational Research, 2016.